These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29718668)

  • 1. Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1.
    Humphrey JM; Movsesian M; Am Ende CW; Becker SL; Chappie TA; Jenkinson S; Liras JL; Liras S; Orozco C; Pandit J; Vajdos FF; Vandeput F; Yang E; Menniti FS
    J Med Chem; 2018 May; 61(10):4635-4640. PubMed ID: 29718668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue.
    Gonçalves RL; Lugnier C; Keravis T; Lopes MJ; Fantini FA; Schmitt M; Cortes SF; Lemos VS
    Eur J Pharmacol; 2009 Oct; 620(1-3):78-83. PubMed ID: 19686719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.
    Li P; Zheng H; Zhao J; Zhang L; Yao W; Zhu H; Beard JD; Ida K; Lane W; Snell G; Sogabe S; Heyser CJ; Snyder GL; Hendrick JP; Vanover KE; Davis RE; Wennogle LP
    J Med Chem; 2016 Feb; 59(3):1149-64. PubMed ID: 26789933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
    Ahn HS; Bercovici A; Boykow G; Bronnenkant A; Chackalamannil S; Chow J; Cleven R; Cook J; Czarniecki M; Domalski C; Fawzi A; Green M; Gündes A; Ho G; Laudicina M; Lindo N; Ma K; Manna M; McKittrick B; Mirzai B; Nechuta T; Neustadt B; Puchalski C; Pula K; Zhang H
    J Med Chem; 1997 Jul; 40(14):2196-210. PubMed ID: 9216839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors.
    Xia Y; Chackalamannil S; Czarniecki M; Tsai H; Vaccaro H; Cleven R; Cook J; Fawzi A; Watkins R; Zhang H
    J Med Chem; 1997 Dec; 40(26):4372-7. PubMed ID: 9435906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new therapeutic approach in Parkinson's disease: some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents.
    Laddha SS; Bhatnagar SP
    Bioorg Med Chem; 2009 Oct; 17(19):6796-802. PubMed ID: 19744861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Evaluation of Dihydropyrimidine Derivatives as Selective PDE1 Inhibitors for the Treatment of Liver Fibrosis.
    Zhao ZJ; Jiang MY; Huang MX; Yang YY; Feng LL; Zhang C; Huang YY; Luo HB; Wu Y
    J Med Chem; 2024 May; 67(10):8309-8322. PubMed ID: 38669059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1.
    Abusnina A; Keravis T; Yougbaré I; Bronner C; Lugnier C
    Mol Nutr Food Res; 2011 Nov; 55(11):1677-89. PubMed ID: 22045655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Ca2+/calmodulin-stimulated cyclic AMP phosphodiesterase (PDE1) activity in Chinese hamster ovary cells (CHO) by phorbol 12-myristate 13-acetate and by the selective overexpression of protein kinase C isoforms.
    Spence S; Rena G; Sweeney G; Houslay MD
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):975-82. PubMed ID: 7575435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction.
    Wennogle LP; Hoxie H; Peng Y; Hendrick JP
    Adv Neurobiol; 2017; 17():349-384. PubMed ID: 28956339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel pyrazolopyrimidone derivatives as potent PDE1 inhibitors.
    Zhang B; Huang Y; Zhang SR; Huang MX; Zhang C; Luo HB
    Bioorg Chem; 2021 Sep; 114():105104. PubMed ID: 34186466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).
    Georget M; Mateo P; Vandecasteele G; Lipskaia L; Defer N; Hanoune J; Hoerter J; Lugnier C; Fischmeister R
    FASEB J; 2003 Aug; 17(11):1380-91. PubMed ID: 12890691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE1A inhibition elicits cGMP-dependent relaxation of rat mesenteric arteries.
    Khammy MM; Dalsgaard T; Larsen PH; Christoffersen CT; Clausen D; Rasmussen LK; Folkersen L; Grunnet M; Kehler J; Aalkjaer C; Nielsen J
    Br J Pharmacol; 2017 Nov; 174(22):4186-4198. PubMed ID: 28910498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats.
    Laursen M; Beck L; Kehler J; Christoffersen CT; Bundgaard C; Mogensen S; Mow TJ; Pinilla E; Knudsen JS; Hedegaard ER; Grunnet M; Simonsen U
    Br J Pharmacol; 2017 Aug; 174(15):2563-2575. PubMed ID: 28548283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors.
    Sánchez AI; Martínez-Barrasa V; Burgos C; Vaquero JJ; Alvarez-Builla J; Terricabras E; Segarra V
    Bioorg Med Chem; 2013 Apr; 21(8):2370-2378. PubMed ID: 23454131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ca
    Kogiso H; Hosogi S; Ikeuchi Y; Tanaka S; Inui T; Marunaka Y; Nakahari T
    Exp Physiol; 2018 Mar; 103(3):381-390. PubMed ID: 29282782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.